MICHAEL M. GARCIA M.D. NPI 1083708762

NPI Details

Michael M. Garcia, M.D. is a medical oncology internal medicine in Jasper, AL with 40 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Michael M. Garcia, M.D. NPI is 1083708762. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE
Graduation Year:1985

The provider's business location address is:

3500 HIGHWAY 78 E STE A
JASPER, AL
ZIP 35501-908
Phone: (256) 705-4224
Fax: (256) 705-4135

The NPI 1083708762 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, levoleucovorin (khapzory), 0.5 mg (HCPCS:J0642)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, ferric derisomaltose, 10 mg (HCPCS:J1437)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Magnesium level (HCPCS:83735)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Phosphate level (HCPCS:84100)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Nephelometry, test method using light (HCPCS:83883)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Unclassified drugs (HCPCS:J3490)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Automated urinalysis test (HCPCS:81003)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Protein measurement, serum (HCPCS:84165)
• Blood creatinine level (HCPCS:82565)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Vitamin d-3 level (HCPCS:82306)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Collection of blood sample from implanted device (HCPCS:36591)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Injection of drug or substance into vein (HCPCS:96374)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)

The enumeration date for this NPI number is 10/3/2006 and was last updated on 4/22/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: